Cemtrex Reports Third Quarter 2022 Financial Results
Cemtrex has reported a 32% increase in Q3 revenues, totaling $13.6 million, compared to $10.3 million in Q3 2021. The company's gross margin improved to 43% from 40% in the previous year, aided by price increases amid rising costs. Despite this growth, the company faced a net loss of $983,491 for the quarter, significantly reduced from a loss of $5.1 million in Q2 2022. Cemtrex is realigning its strategy, focusing on its core business, Vicon Industries, and exploring the divestiture of non-core units to enhance shareholder value.
- Revenue grew by 32% to $13.6 million compared to Q3 2021.
- Gross margin improved to 43%, up from 40% year-over-year.
- Management announced a strategic shift towards core business segments.
- Net loss of $983,491 for Q3 2022, despite improved revenues.
- Operating loss of $2.1 million, although reduced from $3.8 million in Q2 2022.
- Cash and cash equivalents decreased to $11.1 million from $15.4 million year-over-year.
Third Quarter Revenues Increase
Brooklyn, NY, Aug. 15, 2022 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has reported its financial and operational results for the third quarter ended June 30, 2022.
Key Third Quarter 2022 and Subsequent Highlights
- Revenue increased
32% to$13.6 million compared to$10.3 million in Q3’21, marking third straight quarter of increasing revenue. - Q3 gross margin up 310 basis points to
43% in Q3’22 from40% in the prior year quarter and up from32% in Q2’ 22. - Net Income was a
$983,491 loss for the third quarter FY 22, compared to a$5,082,222 loss in the second quarter FY 22, achieving approximately a$4.1 million reduction in expenses over those sequential periods. - Announced a strategic shift towards prioritizing its core businesses, in particular Vicon Industries, its security technology brand to maximize shareholder value, drive long term growth, and profitability. In conjunction with the strategy shift to bolster its Advanced Technologies segment, Cemtrex is exploring the divestiture of one or more business units to support its refocus.
Management Commentary
Cemtrex Chairman and CEO, Saagar Govil, commented on the results: “Along with third straight quarter and year over year improving revenues, the third quarter of 2022 was highlighted by continued quarterly improvement in our Advanced Technologies and Industrial Services segments due to increased demand for our products and services. During the quarter we continued to make significant progress in our strategic shift toward refocusing efforts on our core businesses Vicon Industries and AIS going forward. We believe Vicon can move towards
“To support Vicon’s growth, we recently appointed Haim Shain as Senior Vice President of Product Management at Vicon, a dynamic and accomplished leader in the surveillance industry. In this new role, Shain will oversee the strategy and implementation behind Vicon’s expanding product line, from our award-winning Roughneck® surveillance cameras and VAX access control system, to our centralized video management platform, Valerus™ VMS. Under his leadership, Vicon’s product teams will further drive innovation, including cloud-based video management and AI-enabled video analytics solutions.
“Growth driven by an increase in demand for predictive maintenance services and the rise in the complexity of equipment is driving demand for AIS, our single source industrial contractor and premier provider of industrial contracting services including millwrighting, rigging, piping, electrical, welding. With its strong balance sheet empowering the ability to offer more comprehensive services due to inventory of equipment, we believe the company has enormous untapped potential in the industrial services market.
“For Cemtrex, we continue to evaluate a range of operational and financial alternatives including the sale of one or more of the company’s non-core business units. During the quarter we addressed rising costs by increasing prices and reducing overhead where possible. These steps helped to improve gross margins from
“Looking ahead, we remain focused on disciplined top line growth with room for further gross margin improvement to drive towards positive EBITDA in FY 23. We continue to make strategic investments in our sales and marketing program, ongoing research and development, and advancing our technology partnerships. Vicon is on track to launch a proprietary AI based analytics solution early next year as well as major improvements to its core software platform Valerus, which will further drive growth. We continue to work to position the Company for long-term growth and refocus efforts on our core businesses, which we believe will provide long term value for our shareholders,” concluded Govil.
Third Quarter 2022 Financial Results
Revenue for the three months ended June 30, 2022, and 2021 was
Gross Profit for the third quarter of 2022 was
The Operating loss for the for three months ended June 30, 2022, was
Operating activities for continuing operations used
Net loss for the quarter ended June 30, 2022, was
Cash and cash equivalents totaled
Third Quarter 2022 Results Conference Call
Cemtrex Chief Executive Officer Saagar Govil and Chief Financial Officer Paul Wyckoff will host the conference call, followed by a question-and-answer period.
To access the call, please use the following information:
Date: | Monday August 15, 2022 |
Time: | 5:00 p.m. Eastern time, 2:00 p.m. Pacific time |
Toll-free dial-in number: | 1-844-826-3033 |
International dial-in number: | 1-412-317-5185 |
Conference ID: | 10170222 |
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.
The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1563547&tp_key=b5b432ffa7 and via the investor relations section of the Company's website at www.cemtrex.com.
A replay of the conference call will be available after 8:00 p.m. Eastern time through August 29, 2022.
Toll-free replay number: | 1-844-512-2921 |
International replay number: | 1-412-317-6671 |
Replay ID: | 10170222 |
About Cemtrex
Cemtrex, Inc. (CETX) is a leading multi-industry technology company that is driving innovation in markets such as Internet of Things (IoT), Augmented and Virtual Reality (AR & VR), and Artificial Intelligence and Computer Vision (AI & CV) in a wide range of sectors, including but not limited to consumer products, industrial manufacturing, digital applications, and intelligent security & surveillance systems. www.cemtrex.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the closing of an offering, gross proceeds from an offering, our new product offerings, expected use of proceeds, or any proposed fundraising activities. These forward-looking statements are based on management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by such forward looking statements. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. These risks and uncertainties are discussed under the heading “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release and we undertake no duty to update this information unless required by law.
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited) | ||||||||
June 30, | September 30, | |||||||
Assets | 2022 | 2021 | ||||||
Current assets | ||||||||
Cash and equivalents | $ | 11,442,487 | $ | 15,426,976 | ||||
Restricted cash | 1,518,720 | 1,759,347 | ||||||
Short-term investments | 280,571 | 14,981 | ||||||
Trade receivables, net | 7,564,382 | 7,810,896 | ||||||
Trade receivables - related party | 1,472,514 | 1,487,155 | ||||||
Inventory –net of allowance for inventory obsolescence | 8,458,530 | 5,657,287 | ||||||
Prepaid expenses and other assets | 2,407,116 | 2,585,652 | ||||||
Total current assets | 33,144,320 | 34,742,294 | ||||||
Property and equipment, net | 6,239,239 | 6,738,944 | ||||||
Right-of-use assets | 2,641,960 | 2,940,127 | ||||||
Goodwill | 7,821,283 | 7,821,283 | ||||||
Other | 1,356,766 | 697,240 | ||||||
Total Assets | $ | 51,203,568 | $ | 52,939,888 | ||||
Liabilities & Stockholders' Equity (Deficit) | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 5,401,538 | $ | 4,235,002 | ||||
Short-term liabilities | 17,146,234 | 9,977,972 | ||||||
Lease liabilities - short-term | 819,488 | 830,791 | ||||||
Deposits from customers | 113,106 | 536,220 | ||||||
Accrued expenses | 1,176,787 | 1,621,053 | ||||||
Deferred revenue | 2,594,517 | 2,004,170 | ||||||
Accrued income taxes | 141,465 | 448,194 | ||||||
Total current liabilities | 27,393,135 | 19,653,402 | ||||||
Long-term liabilities | ||||||||
Loans payable to bank | 141,239 | 767,279 | ||||||
Long-term lease liabilities | 1,799,002 | 2,017,408 | ||||||
Notes payable | 228,893 | 2,350,000 | ||||||
Mortgage payable | 2,184,404 | 2,257,785 | ||||||
Other long-term liabilities | 825,629 | 839,171 | ||||||
Paycheck Protection Program Loans | 97,120 | 1,032,200 | ||||||
Deferred Revenue - long-term | 584,003 | 467,967 | ||||||
Total long-term liabilities | 5,860,290 | 9,731,810 | ||||||
Total liabilities | 33,253,425 | 29,385,212 | ||||||
Commitments and contingencies | - | - | ||||||
Shareholders' equity | ||||||||
Preferred stock , | ||||||||
Series 1, 3,000,000 shares authorized, 2,079,122 shares issued and | ||||||||
2,015,022 shares outstanding as of June 30, 2022 and 1,885,151 shares issued and | ||||||||
1,821,051 shares outstanding as of September 30, 2021 (liquidation value of | 2,079 | 1,885 | ||||||
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at | ||||||||
June 30, 2022 and September 30, 2021 | 50 | 50 | ||||||
Common stock, | ||||||||
26,263,296 shares issued and outstanding at June 30, 2022 and | ||||||||
20,782,194 shares issued and outstanding at September 30, 2021 | 26,263 | 20,782 | ||||||
Additional paid-in capital | 66,522,085 | 61,727,834 | ||||||
Retained earnings (accumulated deficit) | (51,788,053 | ) | (41,908,062 | ) | ||||
Treasury stock at cost | (148,291 | ) | (148,291 | ) | ||||
Accumulated other comprehensive income (loss) | 2,555,441 | 2,896,452 | ||||||
Total Cemtrex stockholders' equity | 17,169,574 | 22,590,650 | ||||||
Non-controlling interest | 780,569 | 964,026 | ||||||
Total liabilities and shareholders' equity | $ | 51,203,568 | $ | 52,939,888 |
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss)
(Unaudited)
For the three months ended | For the nine months ended | |||||||||||||||
June 30, 2022 | June 30, 2021 | June 30, 2022 | June 30, 2021 | |||||||||||||
Revenues | 13,630,846 | 10,326,431 | 37,031,550 | 28,422,892 | ||||||||||||
Cost of revenues | 7,754,490 | 6,198,715 | 23,233,389 | 16,360,822 | ||||||||||||
Gross profit | 5,876,356 | 4,127,716 | 13,798,161 | 12,062,070 | ||||||||||||
Operating expenses | ||||||||||||||||
General and administrative | 6,948,959 | 5,670,019 | 20,318,196 | 16,337,200 | ||||||||||||
Research and development | 1,048,246 | 757,966 | 3,474,674 | 2,033,688 | ||||||||||||
Total operating expenses | 7,997,205 | 6,427,985 | 23,792,870 | 18,370,888 | ||||||||||||
Operating income/(loss) | (2,120,849 | ) | (2,300,269 | ) | (9,994,709 | ) | (6,308,818 | ) | ||||||||
Other income/(expense) | ||||||||||||||||
Other income/(expense) | 2,072,265 | 3,901,658 | 3,337,365 | 6,532,590 | ||||||||||||
Settlement Agreement - Related Party | - | - | - | 3,674,165 | ||||||||||||
Interest Expense | (931,059 | ) | (433,009 | ) | (3,654,045 | ) | (1,891,026 | ) | ||||||||
Total other income/(expense), net | 1,141,206 | 3,468,649 | (316,680 | ) | 8,315,729 | |||||||||||
Net loss before income taxes | (979,643 | ) | 1,168,380 | (10,311,389 | ) | 2,006,911 | ||||||||||
Income tax benefit/(expense) | 247,941 | (40,759 | ) | 247,941 | (168,190 | ) | ||||||||||
Net income/(loss) | (731,702 | ) | 1,127,621 | (10,063,448 | ) | 1,838,721 | ||||||||||
Less loss in noncontrolling interest | (50,909 | ) | 29,608 | (183,457 | ) | (20,813 | ) | |||||||||
Net income/(loss) attributable to Cemtrex, Inc. shareholders | $ | (680,793 | ) | $ | 1,098,013 | $ | (9,879,991 | ) | $ | 1,859,534 | ||||||
Other comprehensive income/(loss) | ||||||||||||||||
Net income/(loss) | $ | (731,702 | ) | $ | 1,127,621 | $ | (10,063,448 | ) | $ | 1,838,721 | ||||||
Foreign currency translation loss | (200,880 | ) | (193,554 | ) | (341,011 | ) | (234,045 | ) | ||||||||
Defined benefit plan actuarial gain | - | - | - | 87,895 | ||||||||||||
Comprehensive income/(loss) | (932,582 | ) | 934,067 | (10,404,459 | ) | 1,692,571 | ||||||||||
Less comprehensive loss attributable to noncontrolling interest | 50,909 | (35,731 | ) | 183,457 | 14,524 | |||||||||||
Comprehensive income/(loss) attributable to Cemtrex, Inc. shareholders | $ | (983,491 | ) | $ | 969,798 | $ | (10,587,916 | ) | $ | 1,678,047 | ||||||
Income/(loss) Per Share-Basic | $ | (0.03 | ) | $ | 0.06 | $ | (0.41 | ) | $ | 0.10 | ||||||
Income/(loss) Per Share-Diluted | $ | (0.03 | ) | $ | 0.06 | $ | (0.41 | ) | $ | 0.10 | ||||||
Weighted Average Number of Shares-Basic | 25,777,704 | 18,711,463 | 24,316,527 | 18,368,274 | ||||||||||||
Weighted Average Number of Shares-Diluted | 25,777,704 | 18,711,463 | 24,316,527 | 18,368,274 | ||||||||||||
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
For the nine months ended | ||||||||
June 30, | ||||||||
Cash Flows from Operating Activities | 2022 | 2021 | ||||||
Net income/(loss) | $ | (10,063,448 | ) | $ | 1,838,721 | |||
Adjustments to reconcile net income/(loss) to net cash used by operating activities | ||||||||
Depreciation and amortization | 1,346,383 | 972,186 | ||||||
Loss on disposal of property and equipment | 161,814 | 18,583 | ||||||
Noncash lease expense | 615,354 | 653,175 | ||||||
Change in allowance for doubtful accounts | (7,584 | ) | (161,101 | ) | ||||
Share-based compensation | 111,402 | 110,904 | ||||||
Income tax expense/ (benefit) | (247,941 | ) | 168,190 | |||||
Interest expense paid in equity shares | 1,627,046 | 818,348 | ||||||
Accrued interest on notes payable | 635,001 | 64,748 | ||||||
Amortization of original issue discounts on notes payable | 908,333 | 575,000 | ||||||
Gain on marketable securities | (2,234,478 | ) | (2,407,841 | ) | ||||
Discharge of Paycheck Protection Program Loans | (971,500 | ) | (3,349,700 | ) | ||||
Settlement Agreement - Related Party | - | (3,674,165 | ) | |||||
Changes in operating assets and liabilities net of effects from acquisition | ||||||||
of subsidiaries: | ||||||||
Accounts receivable | 254,098 | 1,613,682 | ||||||
Accounts receivable - related party | 14,641 | (78,594 | ) | |||||
Inventory | (2,801,243 | ) | (1,875,591 | ) | ||||
Prepaid expenses and other current assets | 178,536 | (976,050 | ) | |||||
Other assets | (159,526 | ) | 149,778 | |||||
Other liabilities | (13,542 | ) | 15,019 | |||||
Accounts payable | 1,166,536 | 30,327 | ||||||
Operating lease liabilities | (546,896 | ) | (650,535 | ) | ||||
Deposits from customers | (423,114 | ) | 9,567 | |||||
Accrued expenses | (444,266 | ) | (78,851 | ) | ||||
Deferred revenue | 706,383 | 124,637 | ||||||
Income taxes payable | (58,788 | ) | (88,987 | ) | ||||
Net cash used by operating activities | (10,246,799 | ) | (6,178,550 | ) | ||||
Cash Flows from Investing Activities | ||||||||
Purchase of property and equipment | (1,003,121 | ) | (1,113,658 | ) | ||||
Proceeds from sale of property and equipment | 51,262 | - | ||||||
Investment in MasterpieceVR | (500,000 | ) | (500,000 | ) | ||||
Investment in related party | - | (1,075,428 | ) | |||||
Proceeds from sale of marketable securities | 12,182,932 | 9,134,159 | ||||||
Purchase of marketable securities | (10,214,044 | ) | (6,290,747 | ) | ||||
Net cash used by investing activities | 517,029 | 154,326 | ||||||
Cash Flows from Financing Activities | ||||||||
Proceeds from notes payable | 8,000,000 | - | ||||||
Payments on notes payable | (1,176,763 | ) | (2,145,257 | ) | ||||
Payments on capital lease liabilities | - | (20,061 | ) | |||||
Payments on bank loans | (920,939 | ) | (957,186 | ) | ||||
Proceeds from Paycheck Protection Program Loans | - | 2,942,285 | ||||||
Net cash provided/(used) by financing activities | 5,902,298 | (180,219 | ) | |||||
Effect of currency translation | (397,644 | ) | (386,160 | ) | ||||
Defined benefit plan actuarial gain/(loss) | - | 87,895 | ||||||
Net decrease in cash, cash equivalents, and restricted cash | (3,827,472 | ) | (6,204,443 | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 17,186,323 | 21,072,859 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 12,961,207 | $ | 14,570,151 | ||||
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash | ||||||||
Cash and equivalents | $ | 11,442,487 | $ | 12,879,278 | ||||
Restricted cash | 1,518,720 | 1,690,873 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 12,961,207 | $ | 14,570,151 | ||||
Supplemental Disclosure of Cash Flow Information: | ||||||||
Cash paid during the period for interest | $ | 483,665 | $ | 432,930 | ||||
Cash paid during the period for income taxes | $ | 306,729 | $ | 88,765 | ||||
Supplemental Schedule of Non-Cash Investing and Financing Activities | ||||||||
Investment in Virtual Driver Interactive | $ | - | $ | 439,774 | ||||
Stock issued to pay notes payable | $ | 3,993,124 | $ | 2,187,837 | ||||
Shares issued in connection with note payable | $ | 700,400 | $ | - | ||||
Financing of right of use assets | $ | 317,187 | $ | - | ||||
FAQ
What were Cemtrex's Q3 2022 revenue figures?
How did Cemtrex's gross margin change in Q3 2022?
What was the net income reported by Cemtrex for Q3 2022?
What strategic changes is Cemtrex implementing following Q3 2022 results?